Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Shares withheld for taxes SVP, GENERICS gave up 2,342 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP AND CFO gave up 3,503 shares (to pay taxes)
  3. 4 Shares withheld for taxes PRESIDENT & CEO gave up 13,662 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,460 shares (to pay taxes)
  5. 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,292 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, GENERICS gave up 1,275 shares (to pay taxes)
  7. 4 Open-market sale 10% owner sold 200,000 shares at $38.50 ($7,700,000)
  8. 4 Grant or award SVP, CHIEF HR OFFICER acquired 16,433 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Shares withheld for taxes PRESIDENT & CEO gave up 3,646 shares (to pay taxes)
  11. 4 Open-market sale SVP OPS & PROD DEV sold 18,066 shares at an average $37.26 ($673,069)
  12. 4 Grant or award SR. VP, GENERAL COUNSEL & SEC. acquired 19,280 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award SVP, GENERICS acquired 6,476 shares (grant or award)
  15. 4 Grant or award HEAD OF RARE DISEASE acquired 6,476 shares (grant or award)
  16. 4 Grant or award SVP OPS & PROD DEV acquired 6,644 shares (grant or award)
  17. 4 Grant or award SENIOR VICE PRESIDENT AND CFO acquired 11,291 shares (grant or award)
  18. 4 Grant or award PRESIDENT & CEO acquired 33,352 shares (grant or award)
  19. 4 Grant or award Director acquired 10,049 shares (grant or award)
  20. 4 Grant or award Director acquired 10,049 shares (grant or award)

Page 15 of 42 · 835 filings